Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae

Area of Science:

• Immunology
• Microbiology
• Cell Biology

Background:

• The innate immune system relies on pattern recognition receptors (PRRs) to detect microbial pathogens.
• NOD2 is a key PRR that recognizes muramyl dipeptide (MDP), initiating immune responses including IL-32 production and monocyte-to-dendritic cell (DC) differentiation.
• NOD2's role in leprosy pathogenesis is known, but its activation by Mycobacterium leprae's unique MDP structure is unclear.

Purpose of the Study:

• To investigate the impact of muramyl dipeptide (MDP) structural variations on innate immune responses.
• To determine if Mycobacterium leprae can activate the NOD2 pathway despite its distinct MDP structure.
• To elucidate the role of NOD2 in M. leprae-induced IL-32 production and DC differentiation.

Main Methods:

• Monocyte infection with Mycobacterium leprae.
• Assessment of interleukin-32 (IL-32) production.
• Analysis of dendritic cell (DC) differentiation.
• NOD2-dependent pathway investigation.
• Evaluation of structural variants of MDP, including proximal l-Ala and d-Glu amidation.

Main Results:

• Mycobacterium leprae infection of monocytes induced IL-32 production and DC differentiation in a NOD2-dependent manner.
• The presence of l-Ala instead of Gly in M. leprae's MDP peptide side chain did not hinder NOD2 recognition or cytokine production.
• Amidation of the d-Glu residue in MDP also did not affect NOD2 activation.

Conclusions:

• NOD2 actively recognizes naturally occurring structural variants of muramyl dipeptide (MDP).
• This recognition by NOD2 is crucial for the innate immune response to Mycobacterium leprae, leading to IL-32 production and DC differentiation.
• The study provides experimental evidence supporting NOD2's broad specificity for MDP structures encountered in bacterial infections like leprosy.